What’s Hot in Boston Biotech? Here’s the Agenda

Xconomy Boston — 

There’s just a few weeks left before our annual biotech extravaganza in Boston.

On April 8, we’ll be hosting “What’s Hot in Boston Biotech” at the Broad Institute of MIT and Harvard in Cambridge. We’ve put together a big lineup of executives, scientists, entrepreneurs, and investors across some of the hottest fields of life sciences research—from gene therapy to neuroscience to cell therapy,to the good and bad microbes in your gut—for a series of lively, interactive discussions and panels.

Here are just a few of the speakers you can expect to see:

—David Altshuler: Executive VP of Global Research and CSO, Vertex Pharmaceuticals

—Noubar Afeyan: Managing Partner and CEO, Flagship Ventures

—Tony Coles: CEO, Chairman and Founding Investor, Yumanity Therapeutics

—James Collins: Termeer Professor of Medical Engineering & Science, MIT

—Olivier Danos: Senior Vice President, Gene Therapy, Biogen

—Susan Lindquist: Member, Whitehead Institute, Scientific Founder, Yumanity Therapeutics

—Marian Nakada: VP of Venture Investments, Johnson & Johnson Innovation

We’ve just posted the agenda for the event here. If you don’t have your ticket yet, there are still a few spots up for grabs—you can register here. Just like last year, it’ll be a packed house. See you all on April 8.